CERAM Develop Wide Range Aerosol Sampler for Monitoring Airborne Powder Particles

Health problems caused through the long standing problem of airborne powder particles could soon be a thing of the past, thanks to a novel technique for monitoring airborne powder particles say experts at CERAM.

As a key member of a European Community Framework VI project, CERAM has the responsibility of coordinating testing and sampling of the Wide Range Aerosol Sampler (WRAS) at sites throughout the UK.

WRAS, which was originally developed by scientists at Middlesex University, differs from standard personal hygiene samplers because it uses a pump to draw air through an isokinetic inlet and onto a series of glass slides. Particles travel different distances, depending on their size, before deposition onto one of 7 glass slides. By weighing and carrying out XRD on each of the 7 samples, a particle size distribution for different chemistries can be derived.

Such size distributions can play a critical part in both shaping legislation and ensuring worker health.

Dave Cartlidge of CERAM explained: “Larger particles, when inhaled, have a lower probability of reaching the inner lung, whilst very small particles may be rendered harmless through dissolution in the inner lung fluid. Through mathematical modelling linked to toxicology studies it is possible to predict mg/m-3 level of particles likely to cause harm (which will be a fraction of the total mg m-3 level).”

WRAS can be adapted for monitoring nano as well as micron sized particles and is available for factory monitoring.

For more information on materials testing, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.